Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. September 2022 12:00 ET | Quelle: Innovation1 Biotech Inc.

Innovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directors

NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1'' or the “Company”), a small molecule drug discovery company focused on the clinical development of...
18. August 2022 07:30 ET | Quelle: Innovation1 Biotech Inc.

Innovation1 Biotech Announces Filing of Patent Application for Novel Combination Therapy Targeting Addiction

NEW YORK, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1'' or the “Company”), a small molecule drug discovery company focused on the clinical development of...
11. August 2022 07:30 ET | Quelle: Innovation1 Biotech, Inc.

Innovation1 Biotech Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1” or the “Company”), a small molecule drug discovery company focused on the clinical development of...
04. April 2022 07:30 ET | Quelle: Innovation1 Biotech, Inc.

Innovation1 Biotech (IVBT) Completes Name and Ticker Symbol Change from Gridiron BioNutrients (GMVP)

NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1” or the “Company”), a small molecule drug discovery company focused on the clinical development of...